A public dashboard of research money per death for every cancer
A simple website that shows, every year, how much research money each cancer receives compared with how many people it kills, so the gaps are impossible to ignore.
Combine machine-readable grant data (NIH RePORTER, the International Cancer Research Partnership, UKRI Gateway to Research, EU CORDIS, and charity annual reports) with mortality and DALY data to publish research dollars per death, per DALY and per incident case, by cancer type and by Common Scientific Outline category (biology, prevention, detection, treatment, survivorship). Include a trend line and a 'what would burden-weighted look like' comparison. Cheap, because most of the data are already public; the value is the persistent, cited visibility.
- Funding follows fashion, not burden · Money goes to the cancers and questions that are easy or popular, not the ones that kill most or where a dollar would do most.
- Knowledge reaches practice too slowly · Knowledge diffusion is slow: it takes years for a proven result to change what most patients receive, and no one can keep up with the literature.
Pages like this
not linked directly; found by shared links- IdeaA public tracker of how long each country takes to adopt new evidence
Shares GLOBOCAN / Global Cancer Observatory, SEER (Surveillance, Epidemiology, and End Results), Knowledge reaches practice too slowly.
- JournalCA: A Cancer Journal for Clinicians
Shares GLOBOCAN / Global Cancer Observatory, SEER (Surveillance, Epidemiology, and End Results).
- IdeaA dedicated global financing window for cancer, modelled on the Global Fund
Shares GLOBOCAN / Global Cancer Observatory, Funding follows fashion, not burden.
- IdeaA formal patient-burden score in grant peer review
Shares Burden-weighted portfolio targets for every major cancer funder, Funding follows fashion, not burden.
- IdeaMake a population cancer registry a condition of every cancer aid programme
Shares GLOBOCAN / Global Cancer Observatory, SEER (Surveillance, Epidemiology, and End Results).
- IdeaRing-fence a fifth of national cancer research money for metastasis
Shares GLOBOCAN / Global Cancer Observatory, Funding follows fashion, not burden.
- IdeaSet trial enrolment targets from who actually gets the disease, and publish progress live
Shares GLOBOCAN / Global Cancer Observatory, SEER (Surveillance, Epidemiology, and End Results).
- IdeaA public map of trial deserts to steer where new sites open
Shares GLOBOCAN / Global Cancer Observatory, SEER (Surveillance, Epidemiology, and End Results).